It would have been very interesting to include carcinoma tissue in the study to compare the variant burden and spectrum between early and advanced MSH3-deficient tumours and other MSI- and MSS CRCs, and to identify potential driver genes, relevant for advanced steps of tumourigenesis. This evidence concerns the gene MSH3 and carcinoma.